Mukolitic phytotherapy in respiratory diseases: studies continue
Each year acute bronchitis affects about 5% of the world population. Majority of patients seek medical care when symptoms become severe, especially in the first week of the disease. So far, acute bronchitis is a reason for one million doctor visits per year.
Main Authors: | N. A. Shostak, A. I. Kryukov, N. L. Kunelskaya, A. B. Turovskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2013-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1153 |
Similar Items
-
Acute rhinosinusitis: basic misconceptions and the possibilities of standardized phitotherapy
by: A. Y. Ovchinnikov, et al.
Published: (2016-12-01) -
Mucolytic therapy of acute exacerbations of chronic rhinosinusitis
by: N. L. Kunelskaya, et al.
Published: (2015-12-01) -
Acute bronchitis: challenges of diagnosis and treatment
by: I. V. Leschenko
Published: (2013-12-01) -
Analysis of conjugacy between treatment systems and the efficiency of combined treatment of patients with chronic cholecystitis in combination with chronic opisthorchosis
by: O. A. Poddubnaya, et al.
Published: (2009-08-01) -
Mukolitics in the therapy of respiratory diseases in pediatric practice
by: E. L. Rashitova, et al.
Published: (2020-07-01)